Exelixis
EXEL
#1726
Rank
โ‚ฌ10.52 B
Marketcap
39,11ย โ‚ฌ
Share price
0.46%
Change (1 day)
8.04%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company